NCT06983665 - Human Bioequivalence Study of Liposomal Amphotericin B for Injection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 25, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Invasive Fungal InfectionsNeutropenic FeverVisceral Leishmaniasis

Interventions

DRUG

Test product (Liposomal amphotericin B for injection, Sichuan Huiyu Pharmaceutical Co., Ltd.)

Single intravenous administration of 2.0 mg/kg in each period.

DRUG

Reference product (AmBisome®, Astellas Pharma US Inc.)

Single intravenous administration of 2.0 mg/kg in each period.

Trial Locations (1)

RECRUITING

Jinan Central Hospital, No.105, Jiefang Road,, Jinan

All Listed Sponsors

lead

Sichuan Huiyu Pharmaceutical Co., Ltd

INDUSTRY